Lisa A. Beck, MD

Department of Dermatology
University of Rochester Medical Center
Rochester, New York

Emma Guttman-Yassky, MD PhD

Donald Y. M. Leung, MD, PhD

Edelstein Professor of Pediatric Allergy-Immunology
National Jewish Health
Denver, CO.

Accredited by

American Academy of Allergy Asthma & Immunology

Course Description

Upon completion of this activity, participants should be able to:
- Discuss the basis of emerging anti-cytokine (anti-TH2, Th22 and Th 17) biologics in the treatment of AD
- Discuss other potential therapeutic targets for AD, including JAK inhibitors, PDE4 antagonists, H4R antagonists in AD, and which inflammatory axes are targeted in clinical efficacy and safety data
- Discuss new strategies for preventing AD in hgh risk children and their potential role in preventing other atopic manifestations such as food allergies

Activity Details

Credit Types:CME / MOC / CE
Credit Amount:1.25 Credits
Release Date:2018-May-29
Expiration Date:2020-May-31
Estimated Time for Completion:1 Hour and 15 Minutes
Registration Required:Yes

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.